Business Daily | by Otiato Guguyu
US drug maker Pfizer is lobbying the Kenyan government to include its vaccine as part of the Sh10 billion mass inoculation that has seen Nairobi favour rival firm, AstraZeneca.
The multinational drug firm said it is negotiating with Kenya and other African countries for governments to acquire and approve its vaccine in the global race for mass immunisation against Covid-19.
Kenya says it has set aside Sh10 billion to cover 10 percent of the population and prefers Oxford-AstraZeneca vaccine because it is cheaper and…
